Enhanced tumor delivery of gemcitabine via PEG-DSPE/TPGS mixed micelles.
Enhanced tumor delivery of gemcitabine via PEG-DSPE/TPGS mixed micelles.
复制标题
DOI:
10.1021/mp4005904
复制
发表时间:
2014-04-07
影响因子:
4.9
通讯作者:
Tan C
中科院分区:
文献类型:
--
作者:
Wang Y;Fan W;Dai X;Katragadda U;Mckinley D;Teng Q;Tan C
Gemcitabine is a potent anticancer drug approved for the treatment of pancreatic, non-small-cell lung, breast, and ovarian cancers. The major deficiencies of current gemcitabine therapy, however, are its rapid metabolic inactivation and narrow therapeutic window. Herein, we employed polyethylene glycol-b-distearoylphosphatidylethanolamine (PEG-DSPE)/tocopheryl polyethylene glycol 1000 succinate (TPGS) mixed micelles as a delivery system, to improve the pharmacokinetic characteristics of gemcitabine and enhance its antitumor efficacy. By conjugating stearic acid to gemcitabine and subsequently encapsulating stearoyl gemcitabine (GemC18) within PEG-DSPE/TPGS mixed micelles, the deamination of gemcitabine was delayed in vitro and in vivo. Importantly, compared to free gemcitabine, GemC18-loaded micelles pronouncedly prolonged the circulation time of gemcitabine and elevated its concentration in the tumor by 3-fold, resulting in superior antitumor efficacy in mice bearing human pancreatic cancer BxPC-3 xenografts. Our findings demonstrate the promise of PEG-DSPE/TPGS mixed micelles as a nanocarrier system for the delivery of gemcitabine to achieve safer and more efficacious therapeutic outcomes.
登录
查看更多内容
影响因子:
45.3
作者:
Balar, Arjun V.;Apolo, Andrea B.;Bajorin, Dean F.
通讯作者:
Bajorin, Dean F.
影响因子:
3.6
作者:
Guo, ZW;Gallo, JM
通讯作者:
Gallo, JM
影响因子:
45.3
作者:
Albain, Kathy S.;Nag, Shona M.;O'Shaughnessy, Joyce
通讯作者:
O'Shaughnessy, Joyce
影响因子:
14
作者:
Licciardi, Mariano;Paolino, Donatella;Fresto, Massimo
通讯作者:
Fresto, Massimo
影响因子:
5.8
作者:
Mu, L;Elbayoumi, TA;Torchilin, VP
通讯作者:
Torchilin, VP